|
⚲
|
| Keyboard |
| Arch Venture Partners VIII LLC | |
|---|---|
| Firm | Arch Venture Management LLC |
| Address | c/o Arch Venture Corporation 8725 W Higgins Road, Suite 290 Chicago, IL 60631 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Arch Venture Management LLC | |||||
| Arch Venture Fund VIII Overage LP | 021-235405 | Director | of 150.0 M |
156.0 M | |
| Arch Venture Fund VIII LP | 021-216149 | Director | 400.5 M of 400.5 M |
384.3 M | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2025-10-27 | Buy | 1,915,700 | $2.61 | 4,999,977 |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-12-08 | Other | 703,061 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-12-08 | Other | 1,176,593 | ||
|
Neumora Therapeutics Inc NMRA
Series A-2 Preferred Stock · derivative
|
2023-09-19 | Conversion | 6,576,400 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-09-19 | Buy | 1,500,000 | $17.00 | 25,500,000 |
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-09-19 | Conversion | 2,124,143 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-09-19 | Conversion | 6,576,400 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-09-19 | Conversion | 6,895,021 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-09-19 | Conversion | 1,144,973 | ||
|
Neumora Therapeutics Inc NMRA
Common Stock
|
2023-09-19 | Conversion | 684,167 | ||
|
Neumora Therapeutics Inc NMRA
Series B Preferred Stock · derivative
|
2023-09-19 | Conversion | 2,124,143 | ||
|
Neumora Therapeutics Inc NMRA
Series A-1 Preferred Stock · derivative
|
2023-09-19 | Conversion | 684,167 | ||
|
Neumora Therapeutics Inc NMRA
Series A-1 Preferred Stock · derivative
|
2023-09-19 | Conversion | 1,144,973 | ||
|
Neumora Therapeutics Inc NMRA
Series A-2 Preferred Stock · derivative
|
2023-09-19 | Conversion | 6,895,021 | ||
|
Codiak BioSciences Inc CDAK
Warrant (Right to Buy) · derivative
|
2022-09-13 | Buy | 5,000,000 | ||
|
Codiak BioSciences Inc CDAK
Common Sotck
|
2022-09-13 | Buy | 5,000,000 | $1.50 | 7,500,000 |
|
Quanterix Corp QTRX
Common Stock
|
2020-11-24 | Other | 176,920 | $0.00 | |
|
Quanterix Corp QTRX
Common Stock
|
2020-11-24 | Other | 277,514 | $0.00 | |
|
Quanterix Corp QTRX
Common Stock
|
2020-11-24 | Other | 1,034 | $0.00 | |
|
Quanterix Corp QTRX
Common Stock
|
2020-11-24 | Other | 1,036 | $0.00 | |
| showing 20 of 110 most recent transactions | |||||